标题
Alternative Splicing in Myeloid Malignancies
作者
关键词
-
出版物
Biomedicines
Volume 9, Issue 12, Pages 1844
出版商
MDPI AG
发表日期
2021-12-07
DOI
10.3390/biomedicines9121844
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments
- (2021) Simona Pagliuca et al. Cancers
- Myeloid lncRNA LOUP Mediates Opposing Regulatory Effects of RUNX1 and RUNX1-ETO in t(8;21) AML
- (2021) Bon Q Trinh et al. BLOOD
- Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia
- (2021) Osvaldo D. Rivera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Splicing factor mutations in hematologic malignancies
- (2021) Sisi Chen et al. BLOOD
- Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia
- (2021) Timothy M. Chlon et al. Cell Stem Cell
- Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
- (2021) David P. Steensma et al. LEUKEMIA
- Recurrent SRSF2 mutations in MDS affect both splicing and NMD
- (2020) Mohammad Alinoor Rahman et al. GENES & DEVELOPMENT
- Biomarkers for RBM39 degradation in acute myeloid leukemia
- (2020) David Hsiehchen et al. LEUKEMIA
- Roles and mechanisms of alternative splicing in cancer — implications for care
- (2020) Sophie C. Bonnal et al. Nature Reviews Clinical Oncology
- Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
- (2020) Silvia Belluti et al. Cells
- Complex landscape of alternative splicing in myeloid neoplasms
- (2020) Courtney E. Hershberger et al. LEUKEMIA
- BCL-2 family isoforms in apoptosis and cancer
- (2019) Chloe F. A. Warren et al. Cell Death & Disease
- Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
- (2019) Eric Wang et al. CANCER CELL
- RNA binding proteins in hematopoiesis and hematological malignancy
- (2019) Daniel J. Hodson et al. BLOOD
- Mutational Landscape of the Transcriptome Offers Putative Targets for Immunotherapy of Myeloproliferative Neoplasms
- (2019) Fiorella Schischlik et al. BLOOD
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- Spliceosomal disruption of the non-canonical BAF complex in cancer
- (2019) Daichi Inoue et al. NATURE
- RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines
- (2019) Luhui Shen et al. Scientific Reports
- Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
- (2019) Ilias P. Nikas et al. Cells
- Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
- (2018) Andrea Pellagatti et al. BLOOD
- A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development
- (2018) Marcella Cesana et al. Cell Stem Cell
- Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells
- (2018) Xiangguo Shi et al. EXPERIMENTAL HEMATOLOGY
- Systematic Analysis of Splice-Site-Creating Mutations in Cancer
- (2018) Reyka G. Jayasinghe et al. Cell Reports
- Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells
- (2018) Ksenia S. Anufrieva et al. Genome Medicine
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- CRISPR-Cas guides the future of genetic engineering
- (2018) Gavin J. Knott et al. SCIENCE
- Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
- (2018) Yusuke Shiozawa et al. Nature Communications
- The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
- (2018) Yi-Tsung Yang et al. Blood Cancer Journal
- BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis
- (2018) Shanshan Yu et al. BLOOD
- Noncoding regions are the main source of targetable tumor-specific antigens
- (2018) Céline M. Laumont et al. Science Translational Medicine
- Co-expression networks reveal the tissue-specific regulation of transcription and splicing
- (2017) Ashis Saha et al. GENOME RESEARCH
- Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity
- (2017) Xuewen Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
- (2017) Bon Ham Yip et al. JOURNAL OF CLINICAL INVESTIGATION
- RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
- (2017) Xue-Hai Liang et al. MOLECULAR THERAPY
- Genetic effects on gene expression across human tissues
- (2017) François Aguet et al. NATURE
- Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
- (2017) Ting Han et al. SCIENCE
- Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem Cells
- (2017) Oron Goldstein et al. Stem Cell Reports
- SplAdder: identification, quantification and testing of alternative splicing events from RNA-Seq data
- (2016) André Kahles et al. BIOINFORMATICS
- Splicing-factor alterations in cancers
- (2016) Olga Anczuków et al. RNA
- Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation inSF3B1mutated refractory anaemia with ring sideroblasts
- (2015) Simona Conte et al. BRITISH JOURNAL OF HAEMATOLOGY
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice
- (2014) Y. Komeno et al. BLOOD
- U2AF1mutations alter splice site recognition in hematological malignancies
- (2014) Janine O. Ilagan et al. GENOME RESEARCH
- Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron
- (2014) V Visconte et al. LEUKEMIA
- Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
- (2014) H Dolatshad et al. LEUKEMIA
- A census of human RNA-binding proteins
- (2014) Stefanie Gerstberger et al. NATURE REVIEWS GENETICS
- Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation
- (2013) Justin J.-L. Wong et al. CELL
- A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets
- (2013) Sophia Adamia et al. CLINICAL CANCER RESEARCH
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- The spliceosome as a target of novel antitumour drugs
- (2012) Sophie Bonnal et al. NATURE REVIEWS DRUG DISCOVERY
- The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
- (2011) E. G. Folco et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More